Bong-Yong Lee

USPTO Granted Patents = 17 (Patent Applications = 5)

CIPO Patents = 10

EPO Patents = 12 (Patent Applications = 18)

Average Co-Inventor Count = 7.0

ph-index = 3

Forward Citations = 31(Granted Patents)

Location History:

Seoul-si, KR (2014)
Yongin-si, KR (2017)
Seoul, KR (2013 - 2021)

Company Filing History:

12 out of 199

Sk Chemicals Co., Ltd.

patents

2 out of 76

Daewoong Pharmaceutical Co., Ltd.

Fairchild Korea Semiconductor Ltd.

patents

Years Active: 2013-2021

Loading Chart...

17 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 10981917 - Heterocyclic compound, its preparation method, and pharmaceutical composition comprising the same (2021-04-20),

2. 10696960 - Fusion protein having factor VII activity (2020-06-30),

3. 10155763 - 2-pyridyl substituted imidazoles as ALK5 and/or ALK4 inhibitors (2018-12-18),

4. 9717708 - Process for preparing ertapenem-containing lyophilized formulation (2017-08-01),

5. 9685335 - Power device including a field stop layer (2017-06-20),

6. 9644197 - Fusion protein having factor VII activity (2017-05-09),

7. 9622986 - Percutaneous absorption preparation containing donepezil, and method for preparing same (2017-04-18),

8. 9617328 - Fusion protein having factor IX activity (2017-04-11),

9. 9481684 - Gonadotropin releasing hormone receptor antagonists, method for the preparation thereof and pharmaceutical composition comprising the same (2016-11-01),

10. 9447383 - MDCK-derived cell lines adapted to serum-free culture and suspension culture and method for preparing vaccine virus using the cells (2016-09-20),

11. 9271916 - Composition for reducing skin wrinkles including PDE5 inhibitor (2016-03-01),

12. 9168212 - Composition for eyelash growth (2015-10-27),

13. 9155691 - Composition for reducing skin wrinkles including PDE5 inhibitor (2015-10-13),

14. 9096571 - Picolinamide and pyrimidine-4-carboxamide compounds, process for preparing and pharmaceutical composition comprising the same (2015-08-04),

15. 8809401 - Composition with improved skin penetration for transdermal delivery of tolterodine (2014-08-19),

Title: Innovations by Bong-Yong Lee: A Pioneer in Pharmaceutical Compounds

Introduction

Bong-Yong Lee, a distinguished inventor based in Seoul, South Korea, has made significant contributions to the field of pharmaceuticals. With a remarkable portfolio of 17 patents, he has been instrumental in the development of innovative compounds that address critical health issues.

Latest Patents

Among his recent inventions, Bong-Yong Lee has filed patents for a heterocyclic compound, its preparation method, and a pharmaceutical composition. This particular compound aims at preventing or treating diseases related to abnormalities in prolyl-tRNA synthetase (PRS) activity. In another groundbreaking patent, he developed a fusion protein comprising factor VII and transferrin. This fusion protein exhibits enhanced specific activity compared to existing alternatives, enabling its effective application in therapies utilizing factor VII.

Career Highlights

Throughout his career, Bong-Yong Lee has been associated with reputable companies such as Sk Chemicals Co., Ltd. and Daewoong Pharmaceutical Co., Ltd. His work in these organizations has allowed him to apply his innovative ideas and contribute to significant advancements in pharmaceutical science.

Collaborations

Bong-Yong Lee has collaborated with esteemed colleagues, including Hun-Taek Kim and Jae-Sun Kim. These partnerships have fostered a creative environment that facilitates the advancement of novel therapeutic solutions.

Conclusion

Bong-Yong Lee's innovative spirit and relentless pursuit of excellence have positioned him as a key figure in the realm of pharmaceutical inventions. His contributions continue to inspire future generations of inventors and researchers striving to make a difference in healthcare.

This text is generated by artificial intelligence and may not be accurate.